Get a free Dexcom cap and water bottle!††
Spend $200 or more on Dexcom ONE+ sensors and receive a free Dexcom-branded cap and water bottle - the perfect pair for summer.
This offer is available to both new and existing customers (excluding existing subscriptions), while stocks lasts.
†† T&Cs apply.
Smart device sold separately†
Introducing Dexcom ONE+
The Dexcom ONE+ system features a simple, one-touch sensor applicator and mobile app† that displays both real-time and past data.
With zero fingerpricking,‡ it continuously measures your glucose levels, day and night. It sends 24/7 automatic glucose readings to your smartphone app† or smartwatch.§
‡ If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Ready to experience the Dexcom Difference for FREE?
For a limited time, you can try a Dexcom ONE+ or Dexcom G7 sensor sample at no cost—giving you real-time glucose insights without fingerpricks.‡
*T&Cs apply. ‡ If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
A smart, easy and effective way to manage your diabetes1-5
smart & accurate
- Along with Dexcom G7, Dexcom ONE+ is our most accurate CGM system.5
- The all-in-one sensor lasts for up to 10 days and offers you the flexibility of a 12-hour grace period to swap your sensor when convenient for you.
-1.jpg)
easy
- Easier to get started¶ with fewer components and intuitive in-app onboarding guides through the set-up steps.
- Dexcom ONE+ can also be worn on the upper arm, the abdomen or the upper buttocks (2-6 yrs).
effective outcomes
- Real-time CGM, such as Dexcom ONE+, is proven to improve quality of life and lowering HbA1C and improving time in range.1-7
Manage diabetes confidently and achieve real results with Dexcom.
WHATEVER YOUR GLUCOSE NEEDS ARE, WE HAVE A REAL-TIME CGM FOR YOU.
An easy CGM with essential glucose alerts
- Insulin pump integration not supported
- Type 1 diabetes or type 2 diabetes
- Gestational diabetes
- Up to 5 alert setting options
An advanced CGM with insulin pump connectivity and predictive alerts
- Insulin pump connectivity
- Type 1 diabetes
- Meet targets with the enhanced functionality of Dexcom G7
- Up to 9 alert setting options (including Urgent Low Soon)
Have questions and wish to speak to a Dexcom Representative?
Get started with Dexcom
- Dexcom CGM Systems are funded for New Zealanders with Type 1 diabetes.**
- If you're not eligible for Pharmac Funding, you can purchase our Dexcom ONE+ Monthly Subscription for exclusive loyalty perks and automated shipping.
- Alternatively, you can choose from one of our flexible purchasing options.
Looking to switch to Dexcom ONE+?
For those with a Dexcom G6 or G7 Subscription, complete our cancellation form. Once your subscription is cancelled, you can order your Dexcom ONE+ from our online shop.
Using an insulin pump?
- Please note Dexcom ONE+ is not compatible with insulin pumps
- If you are looking for insulin pump integration, check out Dexcom G7 - our most advanced and connected CGM.
Always read the label and use only as directed. Read the warnings on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you. This product is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
* For terms and conditions please visit dexcom.co.nz/dexcom-sample. † Smart device sold separately. To view a list of compatible smart devices, please visit www.dexcom.com/compatibility. ‡ If your glucose alerts and readings from the device do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. § Compatible device required for CGM data on smartwatch. For a list of compatible devices, visit www.dexcom.com/compatibility. || Compared with a previous Dexcom G6 generation. ¶ Results obtained with a previous generation of Dexcom CGM system and are applicable to Dexcom ONE+ given similar feature sets and better performance and usability. # Time in range was defined as 3.9-10 mmol/L . ^ Dexcom is fully funded under special authority criteria - a prescription item payment may be charged. Eligibility criteria applies. Please visit pharmac.govt.nz. ** Event entry only available on smartphone app. †† For terms and conditions, visit https://nzmsdiabetes.co.nz/trading-terms/
References: 1 Beck, RW, et al. JAMA. 2017;317(4):371-378 2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374 3 Martens T, et al. JAMA. 2021;325(22):2262-2272 4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396 5 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7 6 Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202 7 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S9.
Dexcom, Dexcom G7, Dexcom G6, Dexcom ONE+, Dexcom Follow, Dexcom Clarity and Dexcom Share are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
New Zealand Medical and Scientific Limited is a Dexcom company. 2A Fisher Crescent, Mount Wellington, Auckland 1060
MAT-8530, MAT-8747
